Elevated prostate specific antigen [PSA]

Not billableICD-10-CM diagnosis code.

This code exists but cannot be submitted on its own. It groups the more specific codes beneath it.

Billable FY2016 only, and a category header from FY2017.

Submit one of these 2 more specific codes instead:

R97.20 Elevated prostate specific antigen [PSA]
R97.21 Rising PSA following treatment for malignant neoplasm of prostate

What has happened to this code

Every change the publisher made, from 2007 to now. Entries marked draft are from the pre-implementation releases: ICD-10 took effect on 1 October 2015, so nothing before FY2016 was ever valid on a claim.

FY2007 Added to the draft code set draft Elevated prostate specific antigen [PSA]
FY2017 Stopped being billable

Official coding rules

Published by CDC for FY2027. A rule attached to a category binds every code beneath it, so the rules inherited from this code's ancestors are shown with the code they come from.

Inherited from R97 Abnormal tumor markers

Also known as

Elevated tumor associated antigens [TAA]
Elevated tumor specific antigens [TSA]

Codes in the same group

Code	Description	Status
R97.0	Elevated carcinoembryonic antigen [CEA]	Valid
R97.1	Elevated cancer antigen 125 [CA 125]	Valid
R97.8	Other abnormal tumor markers	Valid